Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Adv Drug Deliv Rev. 2013 Sep 20;0:42–57. doi: 10.1016/j.addr.2013.09.006

Table 1.

Examples of nanoparticle platforms for brain tumors

Material Particle Type Structure
Formed
Size Main component Main Applications Phase of
development
Ref.
Organic Liposomes Colloid
vesicular
strucutre
10nm–1000 nm Lipid Drug carrier Phase I, II
Clinical Trials
[63]
Micelles Nanosphere;
cylinder
20nm–200 nm Polymer Drug carrier Preclinical [64]
Polymeric
nanoparticles
Nanosphere;
nanocapsules
10nm–1000 nm Polymer Drug carrier Preclinical [59]
Dendrimers Branch > 5 nm poly(amidoamine) Drug carrier Preclinical [62]
Inorganic Gold
nanoparticles
Nanosphere;
nanorod;
nanoshell
1nm–100nm Gold Drug carrier;
photothermal
therapy;
photoacoustic
imaging
Preclinical [58,71]
Iron oxide
nanoparticle
Nanosphere 10nm–50nm Iron oxide Drug carrier;
magnetic
hyperthermia; MRI
Phase I, II
Clinical Trials
[57,60]
Ferromagnetic
discs
Microdisk lµm Iron, nickel Magnomechanical
stimulation
Preclinical [61]
Ceramic
nanoparticle
Nanosphere 20nm–100nm Silica Drug carrier Preclinical [235]
Quantum dots Nanosphere;
nanorod
2–20nm Cadmium selenide Fluorescence
imaging
Preclinical [66]
Titanium dioxide
nanocrystals
Sphere 5 nm Titanium dioxide Photodynamic
therapy
Preclinical [67]
Hybrid More than one
type of
nanomaterials
Barge or
tanker
Range
depends
on
materials
selected
Core-metallic and
polymeric;
corona-single or
multiple lipid
layers
Theranostics Preclinical [168]